Follow the Indo Us Biotech Limited stock price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Indo Us Biotech Limited has recorded 6 reports. Market capitalisation: €1.8bn. The latest transaction was reported on 5 March 2026 (Sale). Among the most active insiders: INDO US AGRISEEDS LIMITED. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations